Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Improving the health of vulnerable communities and changing lives is at the heart of what we do and who we are.
The group participates in numerous population studies in malaria-endemic countries, such as Kenya, Papua New Guinea and Thailand, through collaborations with national research institutes based in those countries.
The group centres on malaria immuno-epidemiology and focuses on developing and utilising immunological biomarkers for vaccine trials, disease surveillance and evaluating the impact of interventions for malaria.
Image: Malaria endemic area of PNG
Deputy Program Director, Maternal, Child and Adolescent Health
Evaluation of Malaria Case-Based Reporting using a mobile phone application in Myanmar
Healthy Mothers, Healthy Babies
HMHB: The impact of nutrition, malaria and STIs on pregnant women and infants
Host and parasite factors that predict Artemisinin Resistance reservoirs
Immunity to malaria and infectious diseases during pregnancy
Immunity, drug efficacy and spread of antimalarial drug resistance
Impact of declining transmission on immunity and risk of malaria rebound
Optimal community-delivered malaria elimination models for the Greater Mekong Sub-region
Serological surveillance to identify mosquito exposure and malaria transmission
STRIVE PNG: Stronger Surveillance and Systems Support for Rapid Identification and Containment of Resurgent or Resistant Vector-Borne Pathogens in Papua New Guinea
Doctor Aung Pyae Phyo
Postdoctoral fellow
Doctor Daniela da Silva Goncalves
Research Assistant
Desmond Gul
PhD Student
Eliza Davidson
PhD Candidate
Ellen Kearney
Research Assistant
Professor Freya J.I. Fowkes
Deputy Program Director, Maternal, Child and Adolescent Health
Katherine O’Flaherty
Postdoctoral Scientist
Merryn Roe
PhD Candidate
Doctor Win Han Oo
Senior Program Manager (Health Security)
Accelerating towards elimination of vector-borne diseases such as malaria and lymphatic filariasis requires new approaches to diagnosis, surveillance and intervention.
Humans and pathogens exist in complex populations and environments, which impacts disease transmission and risk, prevention, treatment and public health responses.
Supporting national tuberculosis programs in the Asia-Pacific region to address drug-resistant tuberculosis.
Creating powerful antibody-based biological drugs which will form the basis of next generation therapeutics.
To create and translate knowledge into better health, so no-one is left behind.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2023 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present.
We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
